| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,381 |
16,376 |
$733K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
54,756 |
19,364 |
$707K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,246 |
8,662 |
$579K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
24,639 |
5,834 |
$576K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
16,726 |
6,633 |
$401K |
| 99223 |
Prolong inpt eval add15 m |
4,642 |
3,955 |
$357K |
| 99233 |
Prolong inpt eval add15 m |
8,157 |
2,707 |
$284K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
3,987 |
3,331 |
$168K |
| 99222 |
Initial hospital care, per day, moderate complexity |
2,918 |
2,465 |
$156K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,258 |
970 |
$26K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
260 |
228 |
$24K |
| 99305 |
|
678 |
534 |
$24K |
| 1036F |
|
17,727 |
14,368 |
$14K |
| 90756 |
|
1,521 |
1,087 |
$14K |
| 1123F |
|
7,109 |
5,952 |
$13K |
| 82962 |
|
4,971 |
3,904 |
$8K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
196 |
65 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
68 |
62 |
$4K |
| 99219 |
|
78 |
53 |
$3K |
| 3046F |
|
1,230 |
1,055 |
$2K |
| 99306 |
Prolong nursin fac eval 15m |
29 |
28 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
927 |
658 |
$1K |
| 99217 |
|
44 |
30 |
$1K |
| 3044F |
|
378 |
320 |
$790.14 |
| 99315 |
|
47 |
37 |
$767.80 |
| 99310 |
Prolong nursin fac eval 15m |
20 |
13 |
$706.50 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
15 |
$434.25 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
108 |
68 |
$411.85 |
| 1100F |
|
737 |
309 |
$300.00 |
| 0518F |
|
728 |
303 |
$300.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
7,137 |
6,165 |
$235.83 |
| 86580 |
|
75 |
55 |
$199.31 |
| 3052F |
|
43 |
43 |
$195.00 |
| 4040F |
|
332 |
284 |
$142.07 |
| G0180 |
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
12 |
12 |
$102.88 |
| G0008 |
Administration of influenza virus vaccine |
379 |
280 |
$72.87 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
22,701 |
18,829 |
$55.78 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
18,814 |
15,898 |
$55.47 |
| 82947 |
|
28 |
27 |
$53.42 |
| 3051F |
|
15 |
14 |
$51.50 |
| 81000 |
|
22 |
15 |
$47.88 |
| 90658 |
|
71 |
24 |
$40.98 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
4,434 |
3,940 |
$34.98 |
| 99307 |
|
24 |
16 |
$34.06 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
42,141 |
32,716 |
$0.19 |
| M1179 |
Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 19th birthday and before or during measurement period |
6,292 |
5,659 |
$0.14 |
| M1176 |
Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period |
6,275 |
5,648 |
$0.12 |
| G0030 |
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user |
3,554 |
3,255 |
$0.10 |
| M1173 |
Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period |
5,829 |
5,262 |
$0.08 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
20,215 |
16,918 |
$0.06 |
| M1170 |
Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period |
4,092 |
3,748 |
$0.06 |
| M1168 |
Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period |
2,091 |
1,880 |
$0.05 |
| 4004F |
|
8,248 |
6,781 |
$0.04 |
| G8484 |
Influenza immunization was not administered, reason not given |
5,757 |
4,723 |
$0.01 |
| G8482 |
Influenza immunization administered or previously received |
6,500 |
5,044 |
$0.01 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
14,283 |
12,024 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
6,762 |
5,523 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
8,942 |
7,768 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
8,958 |
7,776 |
$0.00 |
| G9908 |
Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
88 |
85 |
$0.00 |
| M1171 |
Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period |
346 |
322 |
$0.00 |
| G9716 |
Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason |
34 |
30 |
$0.00 |
| M1177 |
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period |
37 |
36 |
$0.00 |
| G0029 |
Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period |
88 |
85 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
791 |
741 |
$0.00 |
| G9905 |
Patient not screened for tobacco use |
115 |
111 |
$0.00 |
| 3045F |
|
55 |
40 |
$0.00 |
| M1174 |
Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period |
30 |
30 |
$0.00 |
| G8421 |
Bmi not documented and no reason is given |
13 |
13 |
$0.00 |
| 1124F |
|
14 |
13 |
$0.00 |